Sales and Marketing

News

GSK reprimanded over "shocking error" in Omjjara info

A complaint against GSK alleging a major breach of the pharma industry's code of practice on prescribing information has been upheld by the PMCPA.

News

EVERSANA adds AI to medical, legal and regulatory reviews

A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.

News

Novo Nordisk returns to ABPI fold after two-year suspension

Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."

News

Novo Nordisk follows Lilly into DTC obesity drug market

Novo Nordisk has launched direct-to-consumer sales of its obesity drug Wegovy for uninsured or under-insured people at $499 per month.

News

Lilly launches discounted high-strength Zepbound vials in US

Eli Lilly's drive to provide as many treatment options as possible for its obesity drug Zepbound has continued with the launch of new high-dose vials.

News

Pfizer drops Beqvez, leaving its gene therapy cupboard bare

Pfizer has abandoned its haemophilia B treatment Beqvez in all world markets, saying weak demand made the business non-viable.

GSK reprimanded over "shocking error" in Omjjara info

EVERSANA adds AI to medical, legal and regulatory reviews

Novo Nordisk returns to ABPI fold after two-year suspension

Novo Nordisk follows Lilly into DTC obesity drug market

Lilly launches discounted high-strength Zepbound vials in US

Pfizer drops Beqvez, leaving its gene therapy cupboard bare

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Sales and Marketing

Editor's Picks